Taken together, these results indicate that engineered genetic disruptions in protein assemblies identified by NeST-VNN can influence tumor cell growth in the setting of CDK4/6 inhibition, whether such inhibition is induced by a drug (Fig. 4b) or CDK4/6 KO (Fig. 4f,g). This evidence concerns the gene IFNG-AS1 and neoplasm.